Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Agnieszka Czechowicz

Agnieszka Czechowicz

individual
Ecosystem influencer

About

Agnieszka Czechowicz, MD, PhD is a Stanford physician-scientist and Assistant Professor of Pediatrics focused on stem cell transplantation, gene therapy/gene editing, and regenerative medicine, with particular clinical interest in Fanconi anemia and other bone marrow failure disorders. Her Stanford profile describes her as scientific co-founder of Magenta Therapeutics and notes prior consulting work with Third Rock Ventures, where she helped start companies including Global Blood Therapeutics, bluebird bio, Editas Medicine, Decibel Therapeutics, and Magenta Therapeutics. She also serves on Prime Medicine's Scientific Advisory Board and has advised multiple cell and gene therapy companies including Beam Therapeutics, Land Medicine, and Spotlight Therapeutics.

Areas of interest

biotechstem cell biologystem cell transplantationgene therapygene editingbase editingprime editingregenerative medicinerare genetic diseasesfanconi anemiahematologyoncologyimmunologyautoimmune diseasemicrobiomecancer